Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-19-274796
Filing Date
2019-10-25
Accepted
2019-10-25 16:31:13
Documents
2
Group Members
FULLERTON MANAGEMENT PTE LTDTEMASEK LIFE SCIENCES PRIVATE LTDTLS BETA PTE. LTD.V-SCIENCES INVESTMENTS PTE LTD

Document Format Files

Seq Description Document Type Size
1 SC 13G d823759dsc13g.htm SC 13G 106098
2 EX-99.1 d823759dex991.htm EX-99.1 7344
  Complete submission text file 0001193125-19-274796.txt   115418
Mailing Address 60B ORCHARD ROAD #06-18 TOWER 2 THE ATRIUM@ORCHARD SINGAPORE U0 238891
Business Address 60B ORCHARD ROAD #06-18 TOWER 2 THE ATRIUM@ORCHARD SINGAPORE U0 238891 65 6828 6828
Temasek Holdings (Private) Ltd (Filed by) CIK: 0001021944 (see all company filings)

EIN.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 0331
Type: SC 13G

Mailing Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158
Business Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Subject) CIK: 0001706431 (see all company filings)

EIN.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91177 | Film No.: 191170239
SIC: 2836 Biological Products, (No Diagnostic Substances)